VANCOUVER, BC / ACCESSWIRE / July 16, 2020 / NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology [...]
NeutriSci International Inc. (the “Company” or “NeutriSci”) announces that its news release issued on July 3, 2020 with respect to a debt settlement was issued in error [...]
NeutriSci International Inc., an innovative technology company developing products for the nutraceutical industry, announces that it will issue 2,060,534 common shares, at a deemed price of $0.05 [...]